News

Discover Frequency Electronics' Fiscal 2025 Conference Call Insights

Discover Frequency Electronics' Fiscal 2025 Conference Call Insights

Frequency Electronics to Discuss Fiscal 2025 Financial Results

Frequency Electronics, Inc. (NASDAQ: FEIM), located in Mitchel Field, N.Y., is set to hold a significant conference call aimed at discussing its financial results for the fiscal year 2025. This call will take place on a Thursday afternoon, focusing on the accomplishments and insights derived from the fiscal year that concluded on April 30, 2025.

Details of the Conference Call

The conference call is scheduled for a specific time and will be accessible to investors and analysts alike. Access to the call will be provided via a convenient dial-in option, ensuring that stakeholders have the opportunity to participate in these critical discussions. Participants can dial 888-506-0062, while international calls can be directed to 973-528-0011. It’s worth noting that participants must reference their access code when joining the call.

About Frequency Electronics and Its Mission

Frequency Electronics is renowned as a leader in the design and manufacturing of high-precision timing, frequency generation, and RF control products. These products are pivotal for various applications, including those within the realms of military, government, and commercial sectors, where precision and reliability are paramount.

Innovative Products and Contributions

The company’s offerings extend to critical infrastructures such as satellite payloads and C4ISR systems, which play vital roles in national security and operational effectiveness. Notably, their innovative solutions include GPS and secure timing technologies, designed specifically for both military and commercial uses. This dedication has not gone unnoticed, as Frequency Electronics has been awarded over 100 awards in recognition of its achievements in providing effective electronic assemblies for numerous defense and space programs.

Looking Towards the Future

Frequency Electronics continuously invests in research and development, demonstrating their commitment to expanding product capabilities and market presence. The company’s mission statement emphasizes their objective to transform breakthrough research into practical applications that serve diverse sectors. This bold vision positions them as a key player in producing unique and innovative frequency generation products.

Continuous Improvement and Future Ambitions

The leadership at Frequency Electronics is dedicated to maintaining excellence in all operational facets, striving to adapt to future needs while simultaneously enhancing value for customers, investors, and employees. This proactive approach ensures the company remains competitive in an evolving technological landscape. They understand that by embracing change and emphasizing quality, they can set themselves apart in the industry.

Conclusion and Contact Information

As the conference call approaches, stakeholders will eagerly anticipate insights regarding Frequency Electronics’ performance and strategic direction. The management team, consisting of Dr. Thomas McClelland and Steven Bernstein, is available for inquiries, ensuring clear communication between the company and its investors.

For further assistance, you can contact Dr. McClelland, President and Chief Executive Officer, or Steven Bernstein, Chief Financial Officer, at the company’s main line at (516) 794-4500 ext.5000. The company’s website also offers additional resources and information for those interested in learning more about Frequency Electronics and its innovative solutions.

Frequently Asked Questions

What is Frequency Electronics known for?

Frequency Electronics, Inc. specializes in high precision timing, frequency generation, and RF control products for various applications, including military and commercial sectors.

When will the conference call take place?

The conference call is scheduled for Thursday at 4:30 PM Eastern Time.

How can participants join the conference call?

Participants can join the conference call by dialing 888-506-0062 for domestic calls or 973-528-0011 for international calls.

What is the mission statement of Frequency Electronics?

Their mission is to turn discoveries from research into practical products that are unmatched in quality and performance, focusing on creating valuable solutions for customers and stakeholders.

Who can I contact for more information about the conference call?

For more details, you can reach out directly to Dr. Thomas McClelland, President and CEO, or Steven Bernstein, CFO, via the company’s contact number.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

DCHFA Appoints Dr. Moreiça Allana-Kim Ortega for Strategic Leadership

Updated Category News Views 325

DCHFA Welcomes Dr. Moreiça Allana-Kim Ortega The District of Columbia Housing Finance Agency (DCHFA) has announced an exciting new direction by creating an Office of Strategic Planning and Performance, under the leadership of Dr. Moreiça Allana-Kim Ortega. This new office is aimed at enhancing the effectiveness of the agency by addressing the evolving needs of housing...

Continue Reading
Cboe Hits Milestone of 1,000 ETFs, Showcasing Growth Trend

Updated Category News Views 120

Cboe Achieves Major Milestone in ETF Listings Cboe Global Markets, Inc. (Cboe: CBOE) has achieved a remarkable feat by surpassing 1,000 U.S.-listed exchange-traded funds (ETFs). This notable accomplishment underscores Cboe's position as a premier venue for innovative actively-managed ETFs. The exchange has welcomed an impressive number of 185 new U.S. ETFs this year,...

Continue Reading
Eat Happy Kitchen Expands Reach with Nationwide Kroger Partnership

Updated Category News Views 1256

Eat Happy Kitchen Expands Retail Presence Nationally In an exciting development for health-conscious shoppers, Eat Happy Kitchen has significantly expanded its reach across the U.S. Nearly 500 stores under the Kroger family umbrella will now feature the woman-owned brand's all-natural line of pasta sauces. This rapid expansion is a testament to the growing demand for...

Continue Reading
ThreeD Capital Reveals December Net Asset Value of $0.76

Updated Category News Views 183

Understanding ThreeD Capital's Recent NAV Announcement ThreeD Capital Inc. is a venture capital firm that carefully evaluates its financial standing to provide clarity to its stakeholders. Recently, the company disclosed that its unaudited net asset value (NAV) per share was valued at $0.76 as of December 31, 2024. This announcement reflects ThreeD’s commitment to...

Continue Reading
Innovative Wealth Planning Tool by Simon Quick Advisors Unveiled

Updated Category News Views 112

Simon Quick Advisors Introduces WealthMetrx™ for Tax Efficiency Simon Quick Advisors, a leading independent wealth management firm, has unveiled a new service called WealthMetrx™. This innovative approach aims to offer clients a comprehensive understanding of their tax profile by transforming intricate data into practical insights. With WealthMetrx™, clients can...

Continue Reading